Literature DB >> 2943356

Plasma alpha natriuretic peptide in cardiac impairment.

A M Richards, J G Cleland, G Tonolo, G D McIntyre, B J Leckie, H J Dargie, S G Ball, J I Robertson.   

Abstract

Regional plasma alpha human atrial natriuretic peptide concentrations were measured, and their relation to intracardiac pressures assessed, in an unselected series of 45 patients undergoing diagnostic cardiac catheterisation. Arteriovenous gradients in plasma concentrations of alpha human atrial natriuretic peptide were consistent with its cardiac secretion and its clearance by the liver and kidneys. Plasma concentrations of the peptide in the pulmonary artery, aorta, and superior vena cava correlated closely with the mean right atrial and pulmonary arterial pressures, and similar, though weaker, positive relations were seen with the left ventricular end diastolic and pulmonary artery wedge pressures. Concentrations of both atrial natriuretic peptide and renin showed significant inverse relations with serum sodium concentrations. Plasma concentrations of alpha human atrial natriuretic peptide are an additional objective indicator of the severity of haemodynamic compromise in patients with cardiac impairment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943356      PMCID: PMC1341233          DOI: 10.1136/bmj.293.6544.409

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  21 in total

1.  Polyuria in paroxysmal tachycardia and paroxysmal atrial flutter and fibrillation.

Authors:  P WOOD
Journal:  Br Heart J       Date:  1963-05

2.  Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia.

Authors:  E L Schiffrin; J Gutkowska; O Kuchel; M Cantin; J Genest
Journal:  N Engl J Med       Date:  1985-05-02       Impact factor: 91.245

3.  Renin relationships in congestive cardiac failure, treated and untreated.

Authors:  J J Brown; D L Davies; V W Johnson; A F Lever; J I Robertson
Journal:  Am Heart J       Date:  1970-09       Impact factor: 4.749

4.  Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.

Authors:  A M Richards; M G Nicholls; H Ikram; M W Webster; T G Yandle; E A Espiner
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

5.  Cardiac secretion of atrial natriuretic peptide.

Authors:  E A Espiner; I G Crozier; M G Nicholls; R Cuneo; T G Yondle; H Ikram
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

6.  Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias.

Authors:  T Yamaji; M Ishibashi; H Nakaoka; K Imataka; M Amano; J Fujii
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

7.  Heart atria granularity effects of changes in water-electrolyte balance.

Authors:  A J De Bold
Journal:  Proc Soc Exp Biol Med       Date:  1979-09

8.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

9.  Alpha-human atrial natriuretic polypeptide is released from the heart and circulates in the body.

Authors:  A Sugawara; K Nakao; N Morii; M Sakamoto; M Suda; M Shimokura; Y Kiso; M Kihara; Y Yamori; K Nishimura
Journal:  Biochem Biophys Res Commun       Date:  1985-06-14       Impact factor: 3.575

10.  Effect of chronic infusion of synthetic atrial natriuretic factor (ANF 8-33) in conscious two-kidney, one-clip hypertensive rats.

Authors:  R Garcia; G Thibault; J Gutkowska; P Hamet; M Cantin; J Genest
Journal:  Proc Soc Exp Biol Med       Date:  1985-01
View more
  27 in total

Review 1.  Vascular tone in heart failure: the neuroendocrine-therapeutic interface.

Authors:  J G Cleland; C M Oakley
Journal:  Br Heart J       Date:  1991-10

2.  Diagnosis of heart failure.

Authors:  J Cleland
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

3.  Physiological hypertrophy of the heart and atrial natriuretic peptide during rest and exercise.

Authors:  J Svanegaard; K Angelo-Nielsen; J S Hansen
Journal:  Br Heart J       Date:  1989-12

4.  Relationship between status of plasma atrial natriuretic peptide and heart rate variability in human subjects.

Authors:  Yuji Kasamaki; Yoichi Izumi; Yukio Ozawa; Masakatsu Ohta; Ayako Tano; Ichiro Watanabe; Atsushi Hirayama; Tomohiro Nakayama; Hiroshi Kawamura; Dilxat Himit; Maisumu Mahemuti; Akira Sezai
Journal:  Heart Vessels       Date:  2012-02-28       Impact factor: 2.037

Review 5.  Atrial natriuretic peptides: clues to their physiological and clinical importance.

Authors:  D R Singer
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

6.  The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.

Authors:  J V Anderson; P W Woodruff; S R Bloom
Journal:  Br Heart J       Date:  1988-02

7.  Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.

Authors:  A M Richards; I G Crozier; T G Yandle; E A Espiner; H Ikram; M G Nicholls
Journal:  Br Heart J       Date:  1993-05

8.  Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.

Authors:  J G Cleland; D Shah; S Krikler; A Dritsas; P Nihoyannopoulos; G Frost; C M Oakley
Journal:  Br Heart J       Date:  1993-06

9.  Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.

Authors:  M Riley; J S Elborn; G Onuoha; C Erwin; C Shaw; M M Khan; C F Stanford; D P Nicholls
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

Review 10.  Outpatient management of heart failure.

Authors:  Mark Richards
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.